These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1698719

  • 1. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
    Fuchs M, Henkel P, Becker-Scheid D, Schmitt J.
    Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P, Langsteger W, Lind P, Klima G, Pierer G, Reisecker F, Eber O.
    Acta Med Austriaca; 1991 Aug; 18 Suppl 1():45-7. PubMed ID: 1719731
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
    Koscielny J, Jung F, Mrowietz C, Pindur G, Förster H, Schimetta W, Kiesewetter H, Wenzel E.
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
    [Abstract] [Full Text] [Related]

  • 8. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U, Hütt M, Herrmann B, Seufzer U, Leweling H.
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch].
    Kortsik CS, Staedt U, Stein T, Geiger G, Buss J.
    Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909
    [Abstract] [Full Text] [Related]

  • 14. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F, Waldhausen P, Spitzer S, Wenzel E.
    Acta Med Austriaca; 1991 Apr; 18 Suppl 1():9-15. PubMed ID: 1719736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J, Haass A, Pindur G, Grauer MT, Jung F, Wenzel E, Schimrigk K.
    Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V, Gille J, Richter A, Sablotzki A, Wiedemann B.
    Anesteziol Reanimatol; 2006 Jan; (2):43-7. PubMed ID: 16758944
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.